论文信息 - High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells - 字舞流文

High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells

A. Müller | C. Bock | J. Loizou | S. Kubicek | R. Kralovics | Anna Koren | P. Májek | M. Schuster | R. Jia | Leon Kutzner | Kathrin Runggatscher